SURFACE ONCOLOGY

SURF NASDAQ
2.670
-0.030
-1.11%
已收盘, 16:00 07/16 EDT
开盘
2.650
昨收
2.700
最高
2.760
最低
2.650
成交量
5,402
成交均量(3M)
7.01万
52周最高
16.38
52周最低
2.470
换手率
0.02%
市值
7,430.50万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供SURFACE ONCOLOGY SURF股票价格,SURFACE ONCOLOGY股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Surface Oncology, Inc. is a clinical-stage immuno-oncology company. The Company is engaged in the development of cancer immunotherapies. To unlock the potential of cancer immunotherapy, the Company is targeting a set of immune processes by which cancer cells evade immune recognition and attack. Its programs are built upon insights about how to improve the immune system’s recognition and elimination of cancer cells. These include approaches to improve the effectiveness of antigen presentation to the adaptive immune system, to block the activity of a range of suppressor cells in the tumor microenvironment, and to counter the immunosuppressive environment that selectively accumulates in and around the tumor. By targeting the interface of innate and adaptive immunity, it hopes to expand the reach of cancer immunotherapy to patients in need of treatment.
展开 >

最近浏览

名称
价格
涨跌幅